CS10 (Cagrilintide 5mg + Semaglutide 5mg) is a high-purity investigational peptide combination developed for scientific research in metabolic regulation pathways.
Semaglutide is a GLP-1 receptor agonist widely studied for its role in glucose metabolism and appetite signaling, while Cagrilintide is an amylin analog researched for its effects on satiety and energy intake regulation. When studied together, this combination is of interest in experimental research exploring multi-pathway metabolic interactions.
CS10 is strictly intended for laboratory and research purposes only and is not approved for human consumption, diagnosis, or treatment of any medical condition.
Key Research Focus Areas:
- Appetite regulation pathways
- Metabolic signaling studies
- GLP-1 and amylin receptor interaction research
- Energy intake and satiety mechanism studies
- Endocrine and peptide receptor research



Reviews
There are no reviews yet.